NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for levofloxacin


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on life sciences reported by researchers at Zhejiang University
2009 OCT 12 ... to triclosan. The resistance rates of triclosan-resistant isolates to imipenem, levofloxacin, amikacin and tetracycline were higher than those of triclosan-sensitive isolates. ...
Subject: Life Sciences
Price: $3.00
*
Data on vasculitis reported by G. Maunz and co-researchers
2009 NOV 16 ... of bacteria[ infection. ALL were treated with a fluoroquinolone (ciprofloxacin or Levofloxacin) combined with rifampin (two cases) or flucloxacillin (three cases), respectively. In ...
Subject: Vasculitis
Price: $3.00
*
Findings from Emory University, Medical Department in antimicrobials reported
2009 NOV 1 ... Patients who were given selected antimicrobial agents (piperacillin-tazobactam, levofloxacin, or vancomycin) by internal medicine ward teams. Twelve internal medicine teams were ...
Subject: Antimicrobials
Price: $3.00
*
Findings from J.N. Lin and co-researchers advance knowledge in mycobacteria
2009 NOV 2 ... by M szulgai and was successfully treated with 4 months of isoniazid, rifampin, and levofloxacin." Lin and colleagues published their study in Southern Medical Journal ...
Subject: Mycobacteria
Price: $3.00
*
New combination therapy looks promising against ulcer bacteria
2009 NOV 9 ... eradicated in 95 percent patients who took a 7-day course of combination therapy with levofloxacin, omeprazole, nitazoxanide (Alinia®) and doxycycline (LOAD) compared to eradication ...
Subject: American College of Gastroenterology
Price: $3.00
*
New pneumonia study findings have been reported from M.E. Falagas et al
2009 NOV 23 ... and the US FDA were appraised. Tigecycline was found to be noninferior compared with levofloxacin for the treatment of patients with bacterial CAP requiring hospitalization. Recently, ...
Subject: Pneumonia
Price: $3.00
*
New Results from Study for Monitoring Antimicrobial Resistance Trends (SMART) Show Rates of In Vitro Susceptibility of E. coli Isolates to Commonly Used Antibiotics
2009 NOV 16 ... 29.24% 25.7-33.0 96.79% 96.0-97.4 levofloxacin 21.93% 18.8-25.4 78.88% 77.2-80.4 ...
Subject: Urinary Tract Infection
Price: $3.00
*
Reports from Technical University of Denmark add new data to research in Escherichia coli
2009 OCT 12 ... oxolinic acid, ciprofloxacin, enrofloxacin, marbofloxacin, norfloxacin, ofloxacin, and levofloxacin. The MIC of levofloxacin was determined by an Etest. ...
Subject: Escherichia coli
Price: $3.00
*
Research in the area of urinary tract infection reported from K.G. Naber and colleagues
2009 NOV 16 ... gram-negative and gram-positive uropathogens, is inferior to IV administration of levofloxacin in the treatment of complicated urinary tract infection (cUTI). (n = 753) with ...
Subject: Urinary Tract Infection
Price: $3.00
*
Research on acute myelogenous leukemia reported by scientists at Kanazawa Medical University
2009 OCT 12 ... (MINO), and the abscess completely disappeared with the oral administration of levofloxacin (LVFX) for about 3 months," wrote T. Fukushima and colleagues, Kanazawa Medical ...
Subject: Acute Myelogenous Leukemia
Price: $3.00
*
Studies from M. Raut and co-authors have provided new information about community-acquired
2009 NOV 2 ... in the journal Current Medical Research and Opinion, "A recent study suggested that levofloxacin significantly reduces the hospital length of stay (LOS), by 0.5 days (p = 0.02), ...
Subject: Community-Acquired
Price: $3.00
*
Studies from M. Sabet and co-authors have provided new information about antimicrobials
2009 NOV 16 ... scientists in the United States report. "MP-376 is a new formulation of levofloxacin that enables the safe aerosol delivery of high concentrations of drug to pulmonary ...
Subject: Antimicrobials
Price: $3.00
*
Studies from University Hospital describe new findings in life sciences
2009 NOV 23 ... 5.0% for tetracycline, 3.9% for clindamycin, and 0.4% for levofloxacin. All isolates were susceptible to amoxycillin (non-meningitis) and telithromycin. The ...
Subject: Life Sciences
Price: $3.00
*
Studies from University of Catania have provided new data on community-acquired
2009 OCT 12 ... cefditoren compared with oral cephalosporins, amoxicillin, amoxicillin/clavulanate and levofloxacin against a randomly selected group of strains isolated from community-acquired ...
Subject: Community-Acquired
Price: $3.00
*
Studies from V.L. Silva and colleagues reveal new findings on diarrhea
2009 OCT 12 ... and almost all the isolates were susceptible to ampicillin-sulbactam (98.4%), levofloxacin (97.8%), and trimethoprim-sulfametoxazole (96.1%)," wrote V.L. Silva and colleagues. ...
Subject: Diarrhea
Price: $3.00
*
Studies in the area of drug resistance reported from University Hospital
2009 NOV 1 ... "Using this model, animals were treated for 7 days with 100 mg/kg/day levofloxacin or 200 mg/kg/12 h cloxacillin, or were left untreated. Antibiotic efficacy was evaluated ...
Subject: Drug Resistance
Price: $3.00
*
Study data from Central Hospital, Department of Urology update understanding of Escherichia coli risk factors
2009 NOV 1 ... of drug-resistant E. coli were determined. The drug susceptibilities of 170 isolates to levofloxacin and cefotaxime or cefpirome were 77% and 96%, respectively. Fluoroquinolone-resistant E. ...
Subject: Escherichia coli Risk Factors
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login